Glioblastoma
Conditions
Keywords
Glioblastoma
Brief summary
Historically, clinical study participation has been biased toward certain demographics. However, there is a shortage of studies that delve into the underlying factors that influence patient participation, both positively and negatively. Several people will be invited to enroll in this study so that it may collect a variety of data about glioblastoma clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal. The data collected from this study will be analyzed and used to improve the experiences of future glioblastoma patients who are recruited for medical trials.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient has self-identified as planning to enroll in a clinical trial * Patient has been diagnosed with glioblastoma * Patient is a minimum of 18 years or older
Exclusion criteria
* Patient does not understand, sign, and return consent form * Inability to perform regular electronic reporting * Patient is pregnant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of patients who decide to participate in a glioblastoma clinical trial | 3 months |
| Rate of patients who remain in glioblastoma clinical trial to trial completion | 12 months |
Contacts
Primary ContactMichael B Gill
Outcome results
None listed